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INTRODUCTION: Bilateral adrenal myelolipoma is a rare benign neoplasm. We presented the case of a
young man affected by a bilateral myelolipoma and the analysis of the literature of bilateral cases of
myelolipoma. Our purpose is to give a suggestion of clear terms of reference regarding the management
of this kind of bilateral neoplasm.
PRESENTATION OF CASE: We reported the case of a 41-year-old healthy man complained of abdominal
pain in the upper quadrants. No signiﬁcant alterations were found in routine blood and endocrinolog-
ical tests. The imaging (CT and MRI) showed a huge right adrenal mass and a smaller lesion at the left
adrenal gland. The preoperative pathological characterization was suggestive for a myelolipoma. A right
open adrenalectomy was performed, and a radiological surveillance was planned for the left tumor. The
pathological exam conﬁrmed the diagnosis.
DISCUSSION: In literature, there are36casesdescribed. The clinical presentation consistedof symptomatic
tumors, incidentally diagnosed lesions or myelolipomas in patients with an associated endocrinal disor-
der. Symptomatic tumors or those bigger than 7 cm, because of the potential risk of rupture, are usually
treated surgically. In smaller (<7 cm) and asymptomatic ones the surgical treatment is not univocal.
CONCLUSION: In the settingof the surgical treatment, it is important topreserve in someway thehormonal
function. For that reason, the bilateral adrenalectomy has to be reserved for symptomatic or sizeable
(>7 cm) cases. As far as we know, this is the ﬁrst review on bilateral myelolipomas.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The adrenal myelolipoma is a rare benign tumor of the adrenal
gland. The incidence in old autopsy-series is about 0.08–0.25%;
however, nowadays it is beingdiagnosedmoreandmore frequently
because of the widespread use of ultrasound, computed tomog-
raphy (CT) and Magnetic Resonance Imaging (MRI). It represents
about 3–5% of primary tumors of the adrenal gland [1].
In general these tumors are asymptomatic, unilateral and small
(on average less than 4 cm). Sometimes they can cause symptoms
because of bulk effects or rupture and also reach impressive dimen-
sions (biggest tumor described measured 31×24.5×11.5 cm and
weighed 5900g) [2]. In some cases, they can be found bilaterally.
So far, the pathogenesis of the myelolipoma is unknown, but
an adrenocortical metaplasia in response to stimuli like necrosis,
inﬂammation, infection or stress [3] is the most common theory.
∗ Corresponding author. Tel.: +39 349 1580491.
E-mail address: davidezattoni@gmail.com (D. Zattoni).
Another hypothesis identiﬁes a stressful lifestyle and a messy diet
as risk factors [4].
Histologically, it is composed of variable mixture of mature adi-
pose tissue and hematopoietic elements. We describe the case of a
young patient with bilateral myelolipoma and present an analysis
of literature regarding the reported cases of bilateral myelolipoma.
The goal of our study was to attempt to identify clinical features
and treatment criteria in this setting. To the best of our knowledge,
this is the ﬁrst review on bilateral cases.
2. Case report
A 41-year-old healthy man complained of abdominal pain after
eating in the upper quadrants from 6 months, without other symp-
toms. No signiﬁcant alterations were found in a routine blood test.
Endocrinological tests and assay of urinary catecholamines did not
show signiﬁcant alterations.
A CT (Fig. 1) highlighted a huge right adrenal mass sized about
17×12 cm (-20HU) and a similar lesion of 2.3×2.5 cm (-5HU)
in the left adrenal gland. MRI (Fig. 2) conﬁrmed the presence of
http://dx.doi.org/10.1016/j.ijscr.2015.04.021
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. CT scan.
Fig. 2. MRI.
bilateral adrenal mass containing mainly fat with multiple septa,
both consistent with myelolipomas.
A CT-guided biopsy of the major lesion showed the presence of
ﬁbroadipose tissue with focal hemosiderosis, without evidence of
neoplastic cells or hematopoietic tissue.
In order to remove the huge symptomatic lesion, we performed
a right open adrenalectomy (Fig. 3), using a Chevron incision. In
order to safely and easily remove the main adrenal lesion (espe-
cially toachieveanadequatecontrol of theadrenal vein), theKocher
maneuver have been required, together with the complete mobi-
lization of the right liver and the right colic ﬂexure, mainly because
the mass being adherent to the right aspect and rear of the inferior
vena cava (Fig. 4). Because of the asymptomatic feature and the
small diameter, in order to preserve the adrenocortical function,
we decided not to surgically remove the myelolipoma on the left
side,monitoring over time its behavior by radiological surveillance.
Thepostoperativeperiodwasuneventful. After one-year follow-
upwithCT-scan,wedidnot ﬁnd relapse on the right side,where the
bigmyelolipomawas removed, and the leftmyelolipoma remained
unchanged.
Macroscopically (Fig. 3), the specimen was a capsulated nodu-
lar lesion of 17 cm in diameter, weighing 1.170kg. The color of
the capsule was yellow mottled. To the cut, the tissue appeared
fairly uniform, adipose and sallow, with hemorrhagic circumfer-
ential zones. The lesion seemed to be originated by the adrenal
medulla with the capsule consisting of the cortex.
Microscopically (Fig. 5), the specimen showed a well-deﬁned
margins tumor, partly bounded by thin connective tissue
Fig. 3. Resected specimen.
capsule, largely consisting of mature adipose tissue with extensive
hemosiderosis. Some areas of hematopoiesis have been identiﬁed,
together with the presence of the three hematopoietic lineages.
In peripheral areas have been discovered the presence of adrenal
tissue with no signiﬁcant histological changes.
CASE REPORT – OPEN ACCESS
D. Zattoni et al. / International Journal of Surgery Case Reports 12 (2015) 31–36 33
Fig. 4. Intraoperative picture showing the tumor bed after removal of the right myelolipoma. a: diaphragm, b: hepatic ﬂexure, c: Gerota’s fascia, d: inferior vena cava, e:
right liver completely mobilized.
3. Method
We researched on PubMed myelolipoma cases described in the
literature until 1st September 2014 using the following search
criteria: myelolipoma, adrenal myelolipoma, adrenal tumor and
adrenal incidentaloma. Moreover, we searched for the paper
cited in the references of the articles about bilateral cases of
myelolipoma.
We excluded monolateral and extra-adrenal myelolipoma
cases. We also analyzed papers from some authors describing sur-
gical series including bilateral cases.
We focused our attention on papers regarding the clinical and
surgical management of these tumors. On the other side, we
excluded from our analysis radiological articles describing only the
radiological presentation of adrenal lesions, without any clinical
description. Regarding the languages, English, Italian and Spanish
articles were analyzed.
4. Discussion
4.1. Epidemiology
Adrenal myelolipoma is a rare benign tumor composed of
mature adipose cells and hematopoietic tissue. Usually adrenal
myelolipoma is a non-functioning, monolateral, small and asymp-
tomatic tumor, and represents the 1.9% of adrenal incidentalomas
[19]. However, bilateral cases of adrenal myelolipoma has been
reported. In our literature search, we found 37 cases [5–23,25] of
bilateralmyelolipoma, excluding thecaseathand,mostlydescribed
in case reports. We excluded from the analysis 18 patients among
those mentioned above because of insufﬁcient data. The average
age of the 19 bilateral cases analyzed was 46 years (range 24–69)
with an equal sex ratio (9 males e 10 females).
4.2. Clinical features and diagnosis
The most frequent clinical feature of bilateral cases described is
monolateral symptoms [6,8,11,13–16,18,21] (9 patients), usually
abdominal discomfort, with the concomitant radiologic ﬁnding of
a contralateral myelolipoma, as in the case at hand.
Sometimes bilateral adrenal tumors were found incidentally
[5,9,10,19] or because of nonspeciﬁc symptoms [23,24] during
radiographic or sonographic exams.
Rarely bilateral myelolipomas were both symptomatic due to
bulk effect (3 patients in our review [12,20,22]).
Routinely, an endocrinological examination was performed
in order to ﬁnd a congenital or secondary endocrinal disorder
or a secreting neoplasm (plasma epinephrine, norepinephrine,
ACTH, cortisol, renin, aldosterone, 17-OH-progesterone, 24h uri-
nary cortisol, free cortisol, metanephrine, vanillymandelic acid and
homovanillic acid); in some case a screening test for congenital
adrenal disorders was performed.
In our case, no signiﬁcant endocrinological alterations were
found, while in the literature we found 11 cases [19–25] of bilat-
eral myelolipomas diagnosed in association with congenital or
acquired endocrine disorders (Table 1). Three cases of eleven were
excluded from our analysis because of missing data (there were
one case of Cushing disease and two cases of adrenal hyperpla-
sia). Fivepatients known tohave anadrenal hyperplasiamanifested
symptoms related to bulk effect with the radiological ﬁnding of a
bilateral adrenal lesion [11,20–23]. In two patients, the diagnosis of
Fig. 5. Microscopical image.
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Table 2
Clinical presentation and management of bilateral adrenal myelolipomas.
Clinical
presentation
Management
Patients Monolateral
adrenalectomy
Bilateral
adrenalectomy
Follow-up
Monolateral
symptoms
9 5 4 0
Bilateral symptoms 4 0 4 0
Incidentaloma 6 1 3 2
Total 19 6 11 2
a bilateral myelolipoma was prior to the discovery of an endocrine
disorder [19,24].
There are no cases reported of bilateral secreting myelolipoma
as well as we did not ﬁnd any case of bilateral myelolipoma with
spontaneous or post-traumatic rupture.
The clinical features and the management of the 18 cases of
bilateral myelolipomas analyzed are shown in Table 2.
As regards the micro-histological characterization, in the case
at hand, a preoperative CT-guided biopsy of the major tumor was
obtained and showed the presence of ﬁbroadipose tissuewith focal
hemosiderosis. The minor one had the same radiological pattern.
In the cases analyzed from the literature, the micro-histological
evaluationwas not routinely performed. Usually an adrenalectomy
was performed precisely in order to achieve a histological con-
ﬁrmation. In most cases, the author reported typical radiological
ﬁndings of myelolipoma, but sometimes the differential diagnosis
with adenoma or liposarcoma may be unclear.
Only two authors reported a histological characterization of the
tumors [5,18]. In four cases [8,14,15,18], the patients underwent
monolateral adrenalectomy for the symptomatic tumorand, during
surgery, a biopsy of the contralateral lesion was obtained, conﬁrm-
ing the diagnosis of myelolipoma and, thus, allowing a planned
follow-up for the lesion left inplace. Eightpatients [6,10–22]under-
went bilateral adrenalectomywithout apreoperative conﬁrmation.
4.3. Treatment
Generally, surgery is considered for symptomatic myelolipo-
mas and also for asymptomatic ones bigger than 7 cm in diameter.
Although bilateral adrenalectomy should be avoided to conserve
the hormonal function, anyway it was performed even in patients
with bilateral asymptomatic tumors because of the diameter larger
than 7 cm and the resulting risk of rupture.
One exception is presented by Ketelsen et al. [5] with a patient
being affected by huge bilateral asymptomatic myelolipoma
(12.3×8.7×19.3 cm on the left and 19.1×10.5×22.6 cm on the
right side) in whom a wait-and-see strategy was adopted, after a
ﬁne-needle-aspiration proof of the benign nature of both lesions.
On the other hand, Jung et al. [19] reported a case of a patient
affected by primary aldosteronism with bilateral myelolipoma of
small dimensions (<7 cm) but with a signiﬁcant growth (more than
30%) of both tumors after one-year follow-up. In this patient, a
partial adrenalectomy was performed on the left side where the
smaller tumor was located and a total one on the other side. The
residual gland was sufﬁcient to maintain the adrenal function, so
a steroid replacement therapy could be avoided, while the aldos-
teronism was solved.
The surgical technique has not been detailed for all interven-
tions. The surgical approach mostly described was a laparotomic
one (n=9), usually using Chevron incision, as in our case. In tumors
less than 10 cm in diameter, successful laparoscopic interventions
are described (n=4). The surgical outcome was good for both
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Table 3
If bilateral adrenalectomy→ steroid replacement is required.
techniques, favoring the laparoscopic approach in terms of length
of stay.
Shen et al. [6] described a new surgical technique, perform-
ing the bilateral myelolipoma excision (left asymptomatic, 8 cm
and right symptomatic, 8.5 cm)with a laparoscopic retroperitoneal
liposuction and subsequent adrenalectomy. No tumor recurrence
was observed [6].
There are no bilateral cases described of emergency inter-
ventions for bleeding due to traumatic or spontaneous rupture.
Conversely, there are 13 cases of unilateralmyelolipomawith hem-
orrhage after spontaneous (11 cases) or post-traumatic (2 case)
rupture. In all cases, the tumors were bigger than 7 cm [31–43].
In two cases of spontaneous hemorrhage, urgent embolization
was performed, followed by delayed elective surgical excision
of the myelolipomas [39,40]. In case of rupture, the adrenalec-
tomy was always planned considering the lesion “symptomatic”
in this setting; for that reason it is not clear the feasibility of
an observational approach with or without embolization, because
conservative strategy had never been used.
All patients submitted to a bilateral adrenal excision received a
lifelong steroid replacement.
A conservative strategy for both bilateral tumors was described
by Ketelsen et al. [5] (giant bilateral asymptomatic myelolipomas)
as mentioned above and by Umpierrez et al. [24], who diagnosed
incidentally two small adrenal lesions (3.5×5 cm on the left and
2×2.5 cmon the right side)with radiological typical characteristics
of myelolipoma.
All asymptomatic tumors less than 7 cm in diameter
[8,9,13–15,23,24] (except for the case reported by Jung et al.,
[19] with signiﬁcant bilateral growth during follow-up) were
managed conservatively, as we performed with the smaller
asymptomatic myelolipoma (2.3×2.5 cm left side). The timing of
follow-up was not always declared by the authors. Usually the
follow-up plan consists in US or CT scan [8,16] or MRI after 12 and
24 months, but there is no uniformity. The tumor growth occurs in
about half of the cases as reported by Han et al. [28], who carried
out a surveillance for an average of 3.2 years (range 0.3–10.8 years)
in a series of 12 patients with myelolipoma (only 1 bilateral case)
and described a tumor growth in 6 patients, decrease in 2, and
dimensional stability in 5.
5. Conclusion
Myelolipoma is a rare benign tumor consisting of a tissue
mix of fat and myeloid cells, usually surrounded by a cap-
sule. Adrenal myelolipoma can be diagnosed incidentally or can
be revealed by symptoms caused by bulk effects (abdominal
pain or distension, ﬂank/back/lumbar/shoulder pain or discom-
fort, palpable abdominal mass, ileus, cardiac dyskinesia, cough) or
spontaneous/post-traumatic rupture [1]. CT, ultrasound and MRI
can all be used for diagnosis, CT having the advantage of the
possibility of tissue density measurement [26]. In the differential
diagnosis, we must consider teratoma, adenoma, lipoma, liposar-
coma and angiomyelolipoma. In order to exclude malignancy and
plan the management strategy, a ﬁne-needle aspiration or a CT- or
ultrasound- guided micro-biopsy are advised [27,28].
Bilateral myelolipomas are also described in association with
endocrinal disorders: congenital adrenal hyperplasia caused by
21-hydroxylase deﬁciency, Cushing disease, primary aldostero-
nism. This may suggest a relationship between the pathogenesis
of myelolipoma and the presence of endocrinal disease, but, as
far as we found, this is still unknown. Only 3 cases of unilateral
myelolipoma with catecholamine secretion [2,29,30] are described
in the literature; no case of bilateralmyelolipoma is reported in this
setting.
Surgical intervention is required in symptomatic tumors and
in tumors bigger than 7 cm, because of the potential risk of rup-
ture [1,8]. Even if, unlike to the unilateral type, in the literature,
there are no cases described of bilateral myelolipoma with tumor
rupture. Myelolipoma can be treated with both conventional and
laparoscopic surgery and in general do not relapse.
Asymptomatic lesions inferior to 7 cm can be left in place, as we
planned in the case at hand. These neoplasms are benign and at low
risk of rupture. This is why it is advised to be conservative, as soon
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as possible, to preserve the hormonal function, on condition that
histological nature is clariﬁed. An annual follow up by CT or MRI is
reasonable.
Finally, whenever possible, the endocrine function must be pre-
served; a partial adrenalectomy can be considered, as described
by Jung et al. [19]. The surgical treatment of the asymptomatic
lesions is not mandatory even if they are bigger than 7 cm, because
of the very low risk of rupture, and a wait-and-see strategy could
be adopted. Decision algorithm in bilateral myelolipoma is shown
in Table 3.
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